文献速递腹部CT

胃癌根治性切除术后患者CT影像组学特征的预后价值

Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection.
PubMed 文献 · Eur Radiol · 2018-12-05

该回顾性研究纳入181例接受根治性切除术的胃癌患者,评估由6个影像特征构成的影像组学标签(R-signature)与总生存期的关联,并在验证队列中验证。整合R-signature与显著临床病理危险因素(T分期、N分期、分化程度)的影像组学列线图预后优于临床列线图及单独R-signature。

要点

  • R-signature由6个影像特征构成,可将根治性切除术后胃癌患者分为高、低预后风险两组。
  • 整合R-signature与T分期、N分期、分化程度的影像组学列线图预后优于临床列线图及单独R-signature。
  • 影像组学可能有助于个性化治疗决策和患者咨询。

核心结论

  • R-signature可用于将根治性切除术后的胃癌患者分层为高风险组和低风险组。
  • 影像组学列线图提供比其他预测模型更好的预测准确性,可能有助于临床医生的治疗决策和患者咨询。

研究设计与样本

  • 回顾性研究,共纳入181例接受根治性切除术的胃癌患者。
  • 在主要队列中评估R-signature与总生存期的关联,并在验证队列中验证。
  • 评估整合R-signature与显著临床病理危险因素的影像组学列线图的性能。

诊断标准与关键数值

  • R-signature由六个影像特征组成,将患者分为两个预后风险组。
  • 影像组学列线图整合R-signature与显著临床病理危险因素(T分期、N分期、分化程度)。
  • Harrell一致性指数:影像组学列线图0.82 vs 临床列线图0.71(p < 0.001),影像组学列线图0.82 vs 单独R-signature 0.74(p < 0.001)。
  • 所有校准曲线显示预测生存与实际生存高度一致,决策曲线分析验证了影像组学列线图在临床实践中的实用性。

临床应用与阅片要点

  • R-signature可用于对根治性切除术后的胃癌患者进行高、低风险分层。
  • 影像组学列线图整合R-signature与T分期、N分期、分化程度,预测准确性优于临床列线图及单独R-signature。
  • 影像组学列线图可能有助于临床医生的治疗决策和患者咨询。
  • 影像组学可提高TNM分期系统的预后价值。
  • 影像组学可能促进胃癌患者的个性化治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The present study aimed to investigate the clinical prognostic significance of radiomics signature (R-signature) in patients with gastric cancer who had undergone radical resection.

METHODS: A total of 181 patients with gastric cancer who had undergone radical resection were enrolled in this retrospective study. The association between the R-signature and overall survival (OS) was assessed in the primary cohort and verified in the validation cohort. Furthermore, the performance of a radiomics nomogram integrating the R-signature and significant clinicopathological risk factors was evaluated.

RESULTS: The R-signature, which consisted of six imaging features, stratified patients with gastric cancer who had undergone radical resection into two prognostic risk groups in both cohorts. The radiomics nomogram incorporating R-signature and significant clinicopathological risk factors (T stage, N stage, and differentiation) exhibited significant prognostic superiority over clinical nomogram and R-signature alone (Harrell concordance index, 0.82 vs 0.71 and 0.82 vs 0.74, respectively, p < 0.001 in both analyses). All calibration curves showed remarkable consistency between predicted and actual survival, and decision curve analysis verified the usefulness of the radiomics nomogram for clinical practice.

CONCLUSIONS: The R-signature could be used to stratify patients with gastric cancer following radical resection into high- and low-risk groups. Furthermore, the radiomics nomogram provided better predictive accuracy than other predictive models and might aid clinicians with therapeutic decision-making and patient counseling.

KEY POINTS: • Radiomics can stratify the gastric cancer patients following radical resection into high- and low-risk groups. • Radiomics can improve the prognostic value of TNM staging system. • Radiomics may facilitate personalized treatment of gastric cancer patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Li W, Zhang L, Tian C, et al. Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection. Eur Radiol. 2018. PMID: 30519931. doi:10.1007/s00330-018-5861-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。